Posted by AGORACOM-JC
at 11:09 AM on Tuesday, May 28th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
NBUD: CSE
—————
Cannabis continues to light up Canadian sec finance
Cannabis stocks continue to drive momentum in the Canadian securities finance market.
According to data from IHS Markit, Canadian equity securities lending revenue reached $144.82 million in 1Q19, up 11.5% on 1Q18.
Louise Fordham
Last year was a somewhat challenging one for the Toronto Stock
Exchange (TSX), with the TSX Composite Index down 11.64% at the end of
2018, says Phil Zywot, managing director and Canada regional securities
finance trading head at BNY Mellon Markets. However, 1Q19 experienced a
rebound. “It’s been the best start to any year in the last 19 years,
with the TSX Composite Index coming up 12.42% in the first quarter,â€
Zywot adds.
Cannabis stocks continue to drive momentum in the Canadian securities
finance market. According to data from IHS Markit, Canadian equity
securities lending revenue reached $144.82 million in 1Q19, up 11.5% on
1Q18. Canadian cannabis stocks accounted for $63 million of 1Q19’s
equity lending revenue, an increase of 32% year on year. In North
America, four of the top 10 revenue-generating stocks in the first
quarter of the year were in the Cannabis sector.
Mark Skowron, senior vice president, global securities lending
trading at Northern Trust, says: “In Canada, one of the main themes of
2018, and likely into 2019, was borrower interest in shares of
cannabis-related companies, as the country legalized the use of
recreational marijuana. Ongoing borrower demand and elevated lending
fees should drive good opportunities for holders of these companies’
shares as the sector is broadly viewed as overpriced.â€
While mining and energy stocks have historically been a key driver of
demand for specials in Canada from a short-selling perspective, recent
demand has been more subdued in these areas and cannabis stocks
currently represent the lion’s share of growth in the Canadian market,
explains Sam Pierson, director, securities finance at IHS Markit. “There
are hedge funds that seem to have a long-term view that it is going to
be hard for Canadian cannabis players to grow into their market caps,â€
he says. “As the market caps have grown so have the short balances, as
share price volatility continues to attract a lot of trading on both
sides.â€
Meanwhile, on the fixed income side, there has been continued
strength on the back of Canada’s AAA rating and the need for high
quality liquid assets (HQLA), notes BNY Mellon’s Zywot. This trend is
expected to continue over 2019.
Collateral diversification
The country’s securities finance market has also seen a move towards
greater collateral diversification. Zywot says: “Canada has generally
been a non-cash collateral, sovereign debt market. Now we are seeing
more equities as collateral, other sovereign debt options as collateral,
and an expansion into corporate bonds as collateral. We have even seen
an expansion into different forms of cash collateral and different
currencies.â€
The industry continues to push for broader collateral options for
Canadian mutual funds. The Canadian Securities Lending Association
(CASLA) is advocating for changes to National Instrument 81-102 in order
to allow mutual funds to accept equities as collateral for securities
lending transactions.
Regulatory change
The Canadian Federal Budget, announced on March 19 2019, laid out
proposed reforms with a bearing on the securities lending industry. This
includes changes to the tax treatment surrounding securities lending
transactions where a non-resident lends Canadian stocks to a Canadian
resident, which aim to ‘prevent non-resident taxpayers from avoiding
Canadian dividend withholding tax on compensation payments made under
cross-border share lending arrangements with respect to Canadian
shares’.
“These regulatory changes have been proposed but not yet
implemented,†says Zywot. “If they do pass, they will be retroactive
back to March 19. Participants both globally and here in Canada are
monitoring the situation closely.â€
2019 has already seen the introduction of new rules that provide
retail investors with access to liquid alternatives, which came into
effect on January 3. Zywot says: “This is potentially a new market
opportunity for the Canadian industry. It may be off to a slow start as
the retail sector gains a better understanding of what the product offer
is, but it should be an avenue of growth over the upcoming years for
the Canadian marketplace.â€
Beneficial owner engagement
While Canadian beneficial owners are typically au fait with, and
accepting of, securities lending practices, Zywot believes there has
been a trend towards increased utilisation of securities lending as a
tool to help generate incremental revenue for their underlying funds.
He says: “We have seen more engagement from securities lending
beneficial owners on all fronts, whether that’s getting into a
securities lending programme if there isn’t one, or looking at an
existing programme to see how they can expand it or consider new trading
strategies, ideas or collateral to further increase the incremental
revenue that it can generate.â€
Posted by AGORACOM-JC
at 4:54 PM on Thursday, May 23rd, 2019
When it went public in September of last year, Bougainville Ventures (BOG:CSE) started out as a cannabis real estate company, providing turnkey greenhouse solutions to tenant growers with a long-term goal of emulating the McDonald’s real estate model. That model is still at the core of BOG but company principals are using their expertise to slowly but surely create a vertically integrated powerhouse. More than just lip service, the Company has announced the following in 2019 and we haven’t even hit June yet:
April 15 – Acquired an interest in 5 Alberta retail locations
April 25 – Binding LOI to construct a Canadian Hemp/CBD processing facility
May 14 – Signed A Sponsored Research Agreement With Israeli R&D Company For A CBD Energy Drink
May 23 – Acquired An American Hemp production and processing company to produce high-quality CBD extracts
We sat down with Bougainville Director, Richard Cindric to find out
how these significant developments all tie in together as the Company
races towards becoming a vertically integrated player.
Posted by AGORACOM-JC
at 7:03 AM on Thursday, May 23rd, 2019
Further to the letter of intent with Worm Castings Farms Inc. Company signed a definitive agreement to complete the acquisition
Under the terms of the Worm Castings Transaction, Bougainville will provide total consideration of 10 million common shares of Bougainville at a deemed price of CAD$0.12 and a cash payment of USD$350,000 in return for 70% of Worm Castings profits.
VANCOUVER, British Columbia, May 23, 2019 — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG) (8BV-FF:Frankfurt Stock Exchange) is pleased to announce that further to the letter of intent (“LOIâ€) with Worm Castings Farms Inc. (“Worm Castingsâ€) announced in the Company news release dated October 29, 2018 the Company signed a definitive agreement to complete the acquisition of Worm Castings (“the Worm Castings Transactionâ€). Worm Castings is the sole owner of an Oregon State Hemp production and processing license, issued by the Oregon State Regulatory approval board, for total consideration consisting of 10 million common shares of Bougainville at a deemed price of CAD$0.12 per share and a cash payment of USD$350,000.
TERMS OF THE TRANSACTION
Under the terms of the Worm Castings Transaction, Bougainville will
provide total consideration of 10 million common shares of Bougainville
at a deemed price of CAD$0.12 and a cash payment of USD$350,000 in
return for 70% of Worm Castings profits.
Subject to completion of the Worm Castings Transaction the board of
directors of Bougainville Director’s will approve the Company to deliver
the final outstanding payment of $USD120,000 to Worm Castings which
will complete the USD$350,000 deposit, which will satisfy Bougainville’s
obligation under the Worm Castings Transaction. Bougainville plans to
invest up to USD$1,000,000 to expand the capacity of Worm Castings in
agriculture, associated infrastructure, and working capital.
Bougainville has secured the services of the Worm Castings founders for a
period of a minimum of five years to aid with the anticipated expansion
of the business in Oregon and the rest of the United States.
President & CEO, Andy Jagpal Comments:
“This acquisition of Worm Casting is a means to further our strategy
of providing large quantities of high-quality CBD extracts. The Worm
Casting Transaction provides Bougainville with a vertically-integrated
and licensed cultivator. In addition to having 10 acres worth of
industrial hemp ready for processing, they possess a premium high
quality cloned feminized hemp plants with 10-15% CBD and 0.3% THC
resulting in maximized CBD oil content within each plant.â€
PRIVATE PLACEMENT FINANCING
Bougainville is also pleased to announce that it has arranged a
private placement (the “Private Placementâ€) of units (each a “Unitâ€) at a
price of $0.12 per Unit basis for gross proceeds of up to $500,000.
Each unit is comprised of one common shares (each a “Shareâ€) of the
Company and one common share purchase warrant (each a “Warrantâ€). Each
Warrant entitles the holder to purchase one additional common share
(each “Warrant Shareâ€) of the Company at an exercise price of $0.25 per
Warrant Share for a term that is 24 months from the date of closing of
the Private Placement.
The Company wishes to correct an error in its news release dated May
1, 2019 in which the Company announced the closing of an oversubscribed
private placement for which 3,166,666 Units were issued at a price of
$0.06 per Unit for $190,000 in gross proceeds (the “Closed Private
Placementâ€). The Closed Private Placement resulted in the issuance of
3,316,666 Units of the Company at a price of $0.06 per Unit for $199,000
in gross proceeds
About Bougainville Ventures, Inc.
Bougainville provides cannabis infrastructure and seed-to-sale
services to I-502 tenant-growers leasing greenhouse facilities space and
providing fully built-out, turnkey solutions and ancillary services
including processing, cannabis expertise and marketing and sales
resources. Greenhouse canopies provide a 50% saving in cultivation cost.
Bougainville has 10,000 square feet of space being prepared for
production in Oroville, Washington state. Bougainville possesses
sufficient land for two more pods of the same size.
For further information, please contact the IR department at [email protected] or by phone at 1-888-395-6399.
FORWARD LOOKING STATEMENTS: This news release
contains certain forward-looking statements within the meaning of
Canadian securities laws. Forward-looking statements are based on the
expectations and opinions of the Company’s management on the date the
statements are made. The assumptions used in the preparation of such
statements, although considered reasonable at the time of preparation,
may prove to be imprecise and, as such, undue reliance should not be
placed on forward-looking statements. The Company expressly disclaims
any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or
otherwise. No regulatory authority has approved or disapproved the
information contained in this news release.
Posted by AGORACOM-JC
at 12:10 PM on Wednesday, May 22nd, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.
How does a business persuade its clients to purchase their product
when marijuana is easily accessible in the market? The ideal approach
lies under the art of marketing, and for some organizations, that
implies an emphasis on wellbeing. That is why some brands are
approaching towards healthier CBD infused edible products, for example, Gluten free edibles.
Much healthier options in the market specifically target the audience
that are health conscious. Additionally, people have started taking
health more serious than ever. To inspire these people and use the
influence on getting more profit, professionals in the market have to
advocate health and wellness in their companies.
CBD edible trends in Los Angeles
Los Angeles is probably the biggest promoter of cannabis in the
planet. In addition to that, it is the world capital of restricting
diets. Many wellbeing focused brands implant marijuana into the dietary
prevailing fashions, which touch base with the tides.
There are options to buy, such as gluten free edibles and cannabis
infused tea. Companies are also incorporating cannabis with ginseng to
guarantee calm.
CBD edibles are getting popular in restaurants
The specific compounds in cannabis have benefits of their own. THC
comes with terrific medical benefits when it comes to alleviate pain and
treat different diseases. On the other hand, CBD plays a role in the
overall promotion of good health. This concept has hit the restaurants
and cafes. Now every now and then, you will see a CBD infused label on
their menus. With its property to provide benefits without altering the
mental and emotional state with euphoria, it is getting even more
popular in the restaurant industry.
The potential market goal for cannabis is to bring it for health
promoting purposes. CBD infused product users will notice a general
uplift in their creativity levels, perseverance and tolerance, self awareness and mood. It will also ultimately make people more conscious of their surroundings and make them more empathetic and open.
Many brands have been instilling scientific researches and putting
them into use by making specific products that address certain issues.
These health issues include anxiety, chronic pain and insomnia as well
as other health problems.
Future of CBD edibles
Currently in the United States, over a thousand brands are claiming
to be the best in the market. However, it is still not a time to decide
which brand stands the best. the number of national level US brands are
very limited in the present times. At this point, there is no data or
clue addressing the main method of cannabis consumption once the
substance gets legal at the federal scale.
The central goal of the industry at this point is to erase
misconceptions and create a sense of awareness in the people regarding
its benefits. For this thing to occur, all health brands relating to
cannabis will play an integral role in the market. Products like Gluten
free CBD edibles do not only hint the variety of the products but also
points towards the importance of CBD edibles health wise.
Tags: Cannabis, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Role of CBD Edibles In Boosting Cannabis Industry $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 8:28 AM on Tuesday, May 21st, 2019
Total revenues were $114,810 for the quarter ended March 31, 2019, compared to $19,010 for the same period prior year, representing a 504% increase year-over-year.
The increase was driven by growth in demand and sales of its hempSMART products in conjunction with the Company’s global expansion program.
Growth Driven by Demand and Sales of hempSMART(TM) Products
ESCONDIDO, Calif., May 21, 2019 – –MARIJUANA COMPANY OF AMERICA, INC. (“MCOA†or the “Companyâ€) (OTCQB: MCOA), an innovative hemp and cannabis corporation, today reported its financial results for the first quarter ended March 31, 2019.
First Quarter 2019 Financial and Operational Highlights:
Total revenues were $114,810 for the quarter ended March 31, 2019,
compared to $19,010 for the same period prior year, representing a 504%
increase year-over-year. The increase was driven by growth in demand and
sales of its hempSMART products in conjunction with the Company’s
global expansion program.
Gross profit for the first quarter of 2019 increased to $74,932,
compared to $8,564 for the same period prior year. Gross margins
expanded to 65.3% in the first quarter of 2019, compared to 45% from the
first quarter of 2018.
Total operating expenses for the first quarter of 2019 were
$989,037, compared to $302,872 for the same period prior year, as a
result of increases in SG&A associated with the growth of the
Company’s dedicated associate sales program for its hempSMART sales.
Net loss from operations was $4.2 million for the quarter ended
March 31, 2019, compared to net income of $4.2 million for the quarter
ended March 31, 2018. The previous year’s income was essentially due to
gain in derivatives.
Usage of cash flow from operations decreased year-over-year to
$207,098 for the quarter ended March 31, 2019, from a cash usage of
$497,250 for the quarter ended March 31, 2018.
Total assets were $2,143,188 for the quarter ended March 31, 2019,
an increase of 12% from $1,919,782 for the quarter ended March 31,
2018. The increase of total assets is due to an increase in cash,
inventory and long-term investments that the Company made in the
quarter.
Total liabilities were $8,087,340 for the quarter ended March 31,
2019, compared to total liabilities of $5,053,887 for the quarter ended
March 31, 2018. The increase of liabilities has largely to do with
derivative liabilities increasing by $2.7 million and convertible notes
issued during the quarter.
In January, Marijuana Company of America announced that its Scio,
Oregon, Hemp Project was underway alongside its 2019 hemp growers
license renewal.
The Company experienced a successful prelaunch of its hempSMART
brand in the United Kingdom in January, followed by a U.S. Patent being
issued for hempSMART Brain™ in February.
In March, the Company entered into a Letter of Intent with Natural
Plant Extract of California to form a joint venture to operate a
California cannabis delivery service named Viva Buds™. The agreement was
completed in April.
“Our first quarter results demonstrate our focus on laying the
foundation and investments to establish our presence in the high-growth
cannabis, hemp and CBD markets,†said Mr. Don Steinberg, Chief Executive
Officer of Marijuana Company of America. “During the quarter, we
successfully prelaunched our hempSMART line of products in the United
Kingdom and promoted them at Super Bowl LIII. Our hempSMART Brain™
product was also issued a U.S. Patent, followed by the exciting news of
our engagement with Natural Plant Extract of California to form a joint
venture to operate a cannabis delivery service. Our passion from the
beginning has been on our hempSMART wellness products, which continue to
successfully generate demand and interest worldwide. As a result, we
have significantly expanded our hemp research and growth business. With
our powerful consortium of partners and joint venture relationships, we
believe we are strategically positioned to vertically integrate our
operations and further increase our revenue potential.â€
“Our first quarter results reflect the full deployment of our
marketing strategies for our products and our commitment to grow and
strengthen shareholder value,†said Mr. Jesus Quintero, Chief Financial
Officer of Marijuana Company of America.â€
Further details about the Company’s financial results are available
in its quarterly report on Form 10-Q, available in the investor
relations section of the Company’s website at www.marijuanacompanyofamerica.com.
About Marijuana Company of America, Inc. MCOA is
a corporation that participates in: (1) product research and
development of legal hemp-based consumer products under the brand name
hempSMART™, which targets general health and well-being; (2) an
affiliate marketing program to promote and sell its legal hemp-based
consumer products containing CBD; (3) leasing of real property to
separate business entities engaged in the growth and sale of cannabis in
those states and jurisdictions where cannabis has been legalized and
properly regulated for medicinal and recreational use; and (4) the
expansion of its business into ancillary areas of the legalized cannabis
and hemp industry as the legalized markets and opportunities in this
segment mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the
FDA’s jurisdiction.
Forward-Looking Statements This
news release contains “forward-looking statements†that are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities, and words such as “anticipate,â€
“seek,†intend,†“believe,†“estimate,†“expect,†“project,†“plan†or
similar phrases may be deemed “forward-looking statements†within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-K, our
quarterly reports on Form 10-Q and other periodic reports filed from
time to time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
Posted by AGORACOM-JC
at 8:09 AM on Wednesday, May 15th, 2019
Announced a non-brokered private placement of up to 13,333,333 units, at a price of $0.30 per unit, for gross proceeds of up to $4Â million
Company plans to use the net proceeds of the offering to hire additional staff for its Canadian operations, pursue M&A opportunities in the United States, including new state license applications, and for general working capital purposes.
Insiders of NORTHBUD have Committed $1 Million as Lead Order
TORONTO, May 15, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) announces a non-brokered private placement of up to 13,333,333 units, at a price of $0.30 per unit, for gross proceeds of up to $4 million. Each unit will be comprised of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to acquire an additional share at a price of $0.40 for a period of 24 months from the date of closing of the offering. Insiders of the Company have demonstrated their commitment to the continued success of the Company by committing to a lead investment of $1 million in the proposed offering. The Company plans to use the net proceeds of the offering to hire additional staff for its Canadian operations, pursue M&A opportunities in the United States, including new state license applications, and for general working capital purposes.
“These funds will be essential to fund ongoing acquisition efforts in
the United States and prepare our Canadian production facility for
operations,†said Ryan Brown, CEO of North Bud Farms.
The offering is expected to be completed on or before May 31, 2019,
subject to the receipt of all necessary regulatory approvals. All
securities issued pursuant to the offering will be subject to a
four-month hold period in accordance with applicable Canadian securities
laws.
As mentioned, certain directors, officers and other insiders have
committed to participate in the offering. Accordingly, any such
participation would be considered a “related party transaction” under
Multilateral Instrument 61-101 – Protection of Minority Security Holders
in Special Transactions (“MI 61-101”). The Company is relying on the
exemptions from the formal valuation requirements and majority of the
minority shareholder approval requirements of MI 61-101 contained in
Section 5.5(a) and Section 5.7(1)(a) in respect of any such related
party transaction on the basis that the fair market value of the
transaction does not exceed more than 25% of the Company’s market
capitalization. The Company expects to file a material change report in
respect of any related party transaction on SEDAR prior to the closing
of the offering, the whole as required by MI 61-101.
Eureka Vapor LLC Update
The Company is pleased to update shareholders on the status of its
planned strategic acquisition of multi-state licensed operator, Eureka
Vapor (“Eurekaâ€), as the companies continue to work towards completing a
definitive agreement. Based on projected timelines for the completion
of the audit of Eureka’s financial statements, the companies expect to
sign a definitive agreement in the third quarter of the 2019 calendar
year.
“We are excited to be joining forces with NORTHBUD to drive strong
long-term revenue growth in both Canada and the United States,†said
Justin Braune, CEO of Eureka Vapor. “The Eureka team continues to
evaluate synergistic acquisitions in multiple U.S. states to expand both
the Eureka Vapor and NORTHBUD brands post-closing of our transaction.â€
Corporate Update
The Company is in the final stages of preparation for submission of
the required evidence package to Health Canada for its cannabis
production facility located in Low, Quebec. Consultants have scheduled
the evidence package for the end of June and it will be submitted to
Health Canada upon its completion.
“We are very excited to be nearing completion of this project,†said
Ryan Brown, CEO of North Bud Farms. “We are equally encouraged by recent
changes in the application process that will allocate more resources to
companies who are operationally ready. The Company will provide an
update post submission of the evidence package.â€
About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros
MMP Inc., is pursuing a licence under The Cannabis Act. North Bud Farms
Inc. is constructing a state-of-the-art purpose-built cannabis
production facility located on 95 acres of Agricultural Land in Low,
Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food
Grade cannabinoid production in preparation for the legalization of
edibles and ingestible products scheduled for October 2019.
Neither the Canadian Securities Exchange (the “CSEâ€) nor its
Regulation Services Provider (as that term is defined in the policies of
the CSE) accepts responsibility for the adequacy or accuracy of this
release.
Forward-looking statements
Certain statements and information included in this press release
that, to the extent they are not historical fact, constitute
forward-looking information or statements (collectively,
“forward-looking statementsâ€) within the meaning of applicable
securities legislation. Forward-looking statements, including those
identified by the expressions “anticipateâ€, “believeâ€, “planâ€,
“estimateâ€, “expectâ€, “intendâ€, “mayâ€, “should†and similar expressions
to the extent they relate to the Company or its management.
Forward-looking statements are based on the reasonable assumptions,
estimates, analysis and opinions of management made in light of its
experience and its perception of trends, current conditions and expected
developments, as well as other factors that management believes to be
relevant and reasonable in the circumstances at the date that such
statements are made, but which may prove to be incorrect.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially from any
future results, performance or achievements expressed or implied by the
forward-looking statements. Such risks and uncertainties include, among
others, the risk factors included in the Company’s final long form
prospectus dated August 21, 2018, which is available under the Company’s
SEDAR profile at www.sedar.com.
Accordingly, readers should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement
speaks only as of the date on which such statement is made. New factors
emerge from time to time, and it is not possible for the Company’s
management to predict all of such factors and to assess in advance the
impact of each such factor on the Company’s business or the extent to
which any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. The Company does not undertake any obligation to update any
forward-looking statements to reflect information, events, results,
circumstances or otherwise after the date hereof or to reflect the
occurrence of unanticipated events, except as required by law including
securities laws. This news release does not constitute an offer to sell
or a solicitation of any offer to buy any securities of the Company.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT: North Bud Farms Inc. Edward Miller VP, IR & Communications Office: (855) 628-3420 ext. 3 [email protected]
Tags: Cannabis, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Arranges Private Placement Financing and Provides Corporate Update $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 12:29 PM on Tuesday, May 14th, 2019
Signed a Sponsored Research Agreement to develop a one of a kind water soluble cannabis-based (CBD) supplement energy drink to improve workout performance
Bougainville agrees to fund certain CBD-based research projects like CBD-Oils, CBD-Creams, and CBD-Supplements.
VANCOUVER, British Columbia, May 14, 2019 — Bougainville Ventures Inc. (CSE:BOG) (Frankfurt:8BV)Â is pleased to announced it has signed a Sponsored Research Agreement to develop a one of a kind water soluble cannabis-based (CBD) supplement energy drink to improve workout performance.
Pursuant to its agreement with an Israeli based research firm
Bougainville agrees to fund certain CBD-based research projects like
CBD-Oils, CBD-Creams, and CBD-Supplements. The first project will be to
develop a formula, which will be a water soluble cannabis-based (CBD)
supplement to boost energy and to improve workout performance.
Terms of the Agreement
Bougainville will pay a 5% Royalty from the sale, transfer or order
disposition of the product, for a period of six (6) years from the
completion of the product. Bougainville will have exclusive rights to
commercialize the product in Canada and first right of refusal to
commercialize the product in the US.
Bougainville Shall pay the Israeli based research firm $25,000 USD
upon the execution of the Definitive Agreement by non-refundable check
dated July 1, 2019. And an additional $50,000 USD shall be paid by
Bougainville in favor of the research firm based on milestones.
Israel is at the Forefront of Medical Cannabis Research
Israel is one of the most progressive nations for medical marijuana
research comes courtesy of the government’s involvement. Not only do
they sponsor the majority of clinical trials, but the Israeli military
has endorsed the cannabinoid THC as part of a treatment program for
post-traumatic stress disorder (PTSD). In 2017 Israel saw more than 110
clinical trials take place. Their topic of study included cannabis as a
treatment for Parkinson’s, multiple sclerosis (MS), Crohn’s disease and
several other forms of chronic pain. Israel dominates the medical
marijuana research space and the Government has plans to build one of
the world’s most extensive medical cannabis research and development
facilities in the world.
Andy Jagpal, President, Comments: “We are excited
to strike a relationship to develop a CBD infused energy drink as
Canada’s edible marijuana market is around the corner from being fully
legal within the year. We are also in contact with processors in Canada
to manufacture the energy drink and with our Saskatchewan-based hemp
farmers to source the CBD for our products.â€
About Bougainville Ventures, Inc.  Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost.
On behalf of the Board of Directors BOUGAINVILLE VENTURES INC.
Andy Jagpal, CEO and Director
For further information, please contact Andy Jagpal at [email protected] or 1-888-395-6399
Tags: CBD, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Bougainville Ventures | Comments Off on Bougainville $BOG.ca Signs a Sponsored Research Agreement for a CBD Energy Drink With Israeli Based R&D Company $CROP.ca $VP.ca NF.ca $MCOA
Posted by AGORACOM-JC
at 8:38 AM on Tuesday, May 14th, 2019
Signed a Letter of Intent with Essence Farms, LLC, to form a joint venture (“JVâ€) called Riverside Hemp Project to run farming operations in California for the purpose of growing, cultivating, manufacturing, extracting and selling legal hemp and hemp-derived CBD.
Marijuana Company of America will provide hemp seeds, genetics, management of operations and standard operating procedures. Essence, a cultivator and land owner, will provide all necessary licenses for the legally compliant growth and sale of hemp in Riverside, California.
ESCONDIDO, Calif., May 14, 2019 (GLOBE NEWSWIRE) — via NetworkWire – MARIJUANA COMPANY OF AMERICA, INC., (“MCOA†or the “Companyâ€) (OTCQB: MCOA), an innovative hemp and cannabis corporation, announced today that the Company has signed a Letter of Intent (“LOIâ€) with Essence Farms, LLC, (“Essenceâ€) to form a joint venture (“JVâ€) called Riverside Hemp Project to run farming operations in California for the purpose of growing, cultivating, manufacturing, extracting and selling legal hemp and hemp-derived CBD.
Through the agreement,
Marijuana Company of America will provide hemp seeds, genetics,
management of operations and standard operating procedures. Essence, a
cultivator and land owner, will provide all necessary licenses for the
legally compliant growth and sale of hemp in Riverside, California.
“MCOA
strives to be a leader in producing and distributing hemp, and we
believe this joint venture will allow the Company to further its vision
by establishing itself as a premier company in the hemp sector,†said
Don Steinberg, Chief Executive Officer of Marijuana Company of America.
“With the ongoing return of net profits this project is expected to
provide MCOA, we are confident that signing this Letter of Intent is
another strategic step for the Company and we look forward to expanding
further in both the cannabis and hemp markets in California. If all goes
according to plan, this will by far be the most financially successful
venture the Company has been involved in.â€
Marijuana Company of
America will receive an 80% return of net profits for the JV on an
ongoing basis, as well as a long-term lease on the property with
favorable lease terms. The project includes up to 500 usable acres of
land in California’s Riverside County that has sufficient water and
power and is specifically suited for large-scale cultivation. The
Company is in the process of sourcing the highest quality seeds that
will yield a high percentage of CBD with legally compliant low levels of
THC. It is projected that each acre will produce 2,500 pounds of hemp
biomass. Based on prevailing fair market rates at this time, the biomass
can be sold for approximately $35 a pound. If the Company processes the
biomass as it intends to do, at least in part, the biomass will produce
a significantly higher financial return. Additionally, the property is
equipped with several large structures that are suitable for the storage
and drying of the hemp plants. A highly experienced cultivation team
has been engaged to manage the operations and cultivation of the farm.
Consummation
of the transaction remains contingent upon satisfactory completion of
due diligence by both parties and completion and agreement on all final
terms and conditions of the engagement. Further details on the terms of
this LOI are available in the Company’s filing, which can be accessed at
www.sec.gov.
About Marijuana Company of America, Inc. MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™, which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry as the legalized markets and opportunities in this segment mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products
containing CBD derived from industrial hemp are not marketed or sold
based upon claims that their use is safe and effective treatment for any
medical condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward-Looking Statements This
news release contains “forward-looking statements†that are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities, and words such as “anticipate,â€
“seek,†intend,†“believe,†“estimate,†“expect,†“project,†“plan†or
similar phrases may be deemed “forward-looking statements†within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-K, our
quarterly reports on Form 10-Q and other periodic reports filed from
time to time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
In 2018, Eureka recognized revenue of approximately CAD$11.5 million*
net profit margin of 16%* from its California and Colorado operations
Anticipates further growth in revenue due to anticipated changes to retail regulation of adult cannabis use in California.
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Cultivation facility is progressing on schedule and on budget, video update below:
Click Image Below
FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.
Tags: CBD, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in All Recent Posts, North Bud Farms Inc | Comments Off on CLIENT FEATURE: North Bud Farms $NBUD.ca Sustainable Low Cost, High Quality #Cannabinoid Production and Procurement $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
